Critical and Diverse Role of Alarmin Cytokines in Parasitic Infections

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2024 Nov 19

PMID 39559705

Authors

Zhou Xing

Suiyi Liu

Xing He

Affiliations

Soon will be listed here.

Abstract

Alarmin cytokines including IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) function as danger signals to trigger host immunity in response to tissue injury caused by pathogenic factors such as parasitic infections. Parasitic diseases also provide an excellent context to study their functions and mechanisms. Numerous studies have indicated that alarmin cytokine released by non-immune cells such as epithelial and stromal cells induce the hosts to initiate a type 2 immunity that drives parasite expulsion but also host pathology such as tissue injury and fibrosis. By contrast, alarmin cytokines especially IL-33 derived from immune cells such as dendritic cells may elicit an immuno-suppressive milieu that promotes host tolerance to parasites. Additionally, the role of alarmin cytokines in parasite infections is reported to depend on species of parasites, cellular source of alarmin cytokines, and immune microenvironment, all of which is relevant to the parasitic sites or organs. This narrative review aims to provide information on the crucial and diverse role of alarmin cytokines in parasitic infections involved in different organs including intestine, lung, liver and brain.

References

He X, Pan W . Role of alarmin cytokines and microRNAs in the host-schistosome interaction. F1000Res. 2018; 7. PMC: 6173124. DOI: 10.12688/f1000research.15695.1. View

Angkasekwinai P, Sodthawon W, Jeerawattanawart S, Hansakon A, Pattanapanyasat K, Wang Y . ILC2s activated by IL-25 promote antigen-specific Th2 and Th9 functions that contribute to the control of Trichinella spiralis infection. PLoS One. 2017; 12(9):e0184684. PMC: 5595335. DOI: 10.1371/journal.pone.0184684. View

Martin R, Damle S, Valentine Y, Zellner M, James B, Lownik J . B1 Cell IgE Impedes Mast Cell-Mediated Enhancement of Parasite Expulsion through B2 IgE Blockade. Cell Rep. 2018; 22(7):1824-1834. PMC: 5832064. DOI: 10.1016/j.celrep.2018.01.048. View

Nie Y, Yang D, Oppenheim J . Alarmins and Antitumor Immunity. Clin Ther. 2016; 38(5):1042-53. PMC: 6314656. DOI: 10.1016/j.clinthera.2016.03.021. View

Henry E, Inclan-Rico J, Siracusa M . Type 2 cytokine responses: regulating immunity to helminth parasites and allergic inflammation. Curr Pharmacol Rep. 2018; 3(6):346-359. PMC: 5794032. DOI: 10.1007/s40495-017-0114-1. View

Owyang A, Zaph C, Wilson E, Guild K, Mcclanahan T, Miller H . Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med. 2006; 203(4):843-9. PMC: 1800834. DOI: 10.1084/jem.20051496. View

Peng H, Zhang Q, Li X, Liu Z, Shen J, Sun R . IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 Macrophages. Sci Rep. 2016; 6:29844. PMC: 4956744. DOI: 10.1038/srep29844. View

Vacca F, Chauche C, Jamwal A, Hinchy E, Heieis G, Webster H . A helminth-derived suppressor of ST2 blocks allergic responses. Elife. 2020; 9. PMC: 7234810. DOI: 10.7554/eLife.54017. View

Huang Y, Guo L, Qiu J, Chen X, Hu-Li J, Siebenlist U . IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. Nat Immunol. 2014; 16(2):161-9. PMC: 4297567. DOI: 10.1038/ni.3078. View

10.

Corren J, Ziegler S . TSLP: from allergy to cancer. Nat Immunol. 2019; 20(12):1603-1609. DOI: 10.1038/s41590-019-0524-9. View

11.

He X, Xie J, Wang Y, Fan X, Su Q, Sun Y . Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33. PLoS Pathog. 2018; 14(3):e1006957. PMC: 5875897. DOI: 10.1371/journal.ppat.1006957. View

12.

Autier B, Manuel C, Lundstroem-Stadelmann B, Girard J, Gottstein B, Gangneux J . Endogenous IL-33 Accelerates Metacestode Growth during Late-Stage Alveolar Echinococcosis. Microbiol Spectr. 2023; :e0423922. PMC: 10101030. DOI: 10.1128/spectrum.04239-22. View

13.

El-Naccache D, Hasko G, Gause W . Early Events Triggering the Initiation of a Type 2 Immune Response. Trends Immunol. 2021; 42(2):151-164. PMC: 9813923. DOI: 10.1016/j.it.2020.11.006. View

14.

Engwerda C, Ng S, Bunn P . The Regulation of CD4(+) T Cell Responses during Protozoan Infections. Front Immunol. 2014; 5:498. PMC: 4195384. DOI: 10.3389/fimmu.2014.00498. View

15.

Munoz-Antoli C, Cortes A, Santano R, Sotillo J, Esteban J, Toledo R . Interleukin-25 Induces Resistance Against Intestinal Trematodes. Sci Rep. 2016; 6:34142. PMC: 5034261. DOI: 10.1038/srep34142. View

16.

Divekar R, Kita H . Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol. 2014; 15(1):98-103. PMC: 4346181. DOI: 10.1097/ACI.0000000000000133. View

17.

Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

18.

Abd Rachman Isnadi M, Chin V, Majid R, Lee T, Abdullah M, Bello Omenesa R . Critical Roles of IL-33/ST2 Pathway in Neurological Disorders. Mediators Inflamm. 2018; 2018:5346413. PMC: 5817350. DOI: 10.1155/2018/5346413. View

19.

Maggi L, Camelo G, Rocha I, Alves W, Moreira J, Pereira T . Role of the IL-33/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by Granulomas in Mice. Int J Mol Sci. 2023; 24(12). PMC: 10299179. DOI: 10.3390/ijms241210237. View

20.

Zaiss M, Maslowski K, Mosconi I, Guenat N, Marsland B, Harris N . IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity. PLoS Pathog. 2013; 9(8):e1003531. PMC: 3731249. DOI: 10.1371/journal.ppat.1003531. View